[149 Pages Report] The global atherectomy devices market accounted is projected to reach USD 1.45 Billion by 2022 from USD 1.02 Billion in 2016, at a CAGR of 6.1% during the forecast period.

Years considered for the study are as follows:

Base Year: 2016

Forecast Period: 2017�2022

Objectives of the study are

To define, describe, segment and forecast the global market on the basis of product, application, end user, and region

To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the growth opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players

To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To profile the key market players active in the global atherectomy devices industry and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as new product developments & commercialization, acquisitions, market expansions, and agreements & collaborations in the atherectomy devices market

This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover�s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

In 2016, Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US) held the leading position in the global atherectomy devices market. In the past three years, these companies adopted product launches, strategic acquisitions, mergers, agreements, collaborations, and expansions as their key business strategies to ensure market dominance. Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US) are some of the other major players in this market.

Stakeholders

Original equipment manufacturers (OEMs)

Product sales and distribution companies

Healthcare service providers (hospitals and surgical centers)

Non-government organizations

Government regulatory authorities

Research laboratories and academic institutes

Clinical research organizations (CROs)

Research and development companies

Market research and consulting firms

Scope of the Report

This report categorizes the global market into the following segments and sub segments:

Global Atherectomy Devices Market, by Product

Directional Atherectomy Devices

Orbital Atherectomy Devices

Photo-Ablative Atherectomy Devices

Rotational Atherectomy Devices

Support Devices

Global Atherectomy Devices Market, by Application

Peripheral Vascular

Cardiovascular

Neurovascular

Global Atherectomy Devices Market, by End User

Hospitals & Surgical Centers

Ambulatory Care Centers

Research Laboratories & Academic Institutes

Global Atherectomy Devices Market, by Region

North America US Canada

Europe Germany France UK RoE

Asia Pacific Japan China India RoAPAC

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Further breakdown of the regional atherectomy devices market into countries:

RoW into Latin America, the Middle East, and Africa.

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

This report broadly segments the market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Based on end user, the market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the Atherectomy Devices Market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst